UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I/II Study of Preoperative Radiation and Docetaxel Activity Study for High-Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S390-S390

2011

Volltextzugriff (PDF)

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Cancer treatment and research communications, 2018, Vol.16, p.18-23

2018

Volltextzugriff (PDF)

Erythrocyte fatty acids and prostate cancer risk: A comparison of methods

Prostaglandins, leukotrienes and essential fatty acids, 2010-09, Vol.83 (3), p.161-169

2010

Volltextzugriff (PDF)

Phase I Study of Preoperative Radiation and Docetaxel for High-risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S13-S13

2009

Volltextzugriff (PDF)

Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer

British journal of cancer, 2004-10, Vol.91 (8), p.1425-1427

2004

Volltextzugriff (PDF)

Intermittent chemotherapy in metastatic androgen-independent prostate cancer

British journal of cancer, 2003-09, Vol.89 (6), p.968-970

2003

Volltextzugriff (PDF)

Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer

Urology (Ridgewood, N.J.), 2004-05, Vol.63 (5), p.934-939

2004

Volltextzugriff (PDF)

Statins and Prostate Cancer Risk: A Case-Control Study

American journal of epidemiology, 2005-08, Vol.162 (4), p.318-325

2005

Volltextzugriff (PDF)

Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer

Journal of clinical oncology, 2003-01, Vol.21 (1), p.123-128

2003

Volltextzugriff (PDF)

The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated)

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e562-e563

2020

Volltextzugriff (PDF)

Delayed therapy with curative intent in a contemporary prostate cancer watchful‐waiting cohort

BJU international, 2004-03, Vol.93 (4), p.510-515

2004

Volltextzugriff (PDF)

The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S13-S14

2018

Volltextzugriff (PDF)

SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION: A RARE COMPLICATION OF PROSTATE CANCER

The Journal of urology, 2001-10, Vol.166 (4), p.1386-1386

2001

Volltextzugriff (PDF)

Improved Detection of Prostate Cancer Using Classification and Regression Tree Analysis

Journal of clinical oncology, 2005-07, Vol.23 (19), p.4322-4329

2005

Volltextzugriff (PDF)

Primary primitive neuroectodermal tumor of the kidney : Case report and review of the literature

American journal of clinical pathology, 1996-09, Vol.106 (3), p.339-344

1996

Volltextzugriff (PDF)

Testosterone Loss and Estradiol Administration Modify Memory in Men

The Journal of urology, 2006, Vol.175 (1), p.130-135

2006

Volltextzugriff (PDF)

Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation

The Journal of experimental medicine, 1997-12, Vol.186 (11), p.1831-1841

1997

Volltextzugriff (PDF)

Multimodal therapy for neoplasms arising from a vesical diverticulum

Journal of surgical oncology, 1996-05, Vol.62 (1), p.46-48

1996

Volltextzugriff (PDF)

Phase I/II study of preoperative intensity-modulated radiation therapy (IMRT) and docetaxel for high-risk prostate cancer: A platform for radiosensitizer development

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS250-TPS250

2010

Volltextzugriff (PDF)

A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer

International journal of radiation oncology, biology, physics, 2003-09, Vol.57 (1), p.29-32

2003

Volltextzugriff (PDF)

Agent orange as a risk factor for high-grade prostate cancer detected on initial prostate biopsy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4667-4667

2011

Volltextzugriff (PDF)

Agent orange as a risk factor for positive prostate biopsy

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.178-178

2011

Volltextzugriff (PDF)

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

The lancet oncology, 2013-08, Vol.14 (9), p.893-900

2013

Volltextzugriff (PDF)

ANDROGEN DEPRIVATION WITH SALVAGE SURGERY FOR RADIORECURRENT PROSTATE CANCER: RESULTS AT 5-YEAR FOLLOWUP

The Journal of urology, 1998-03, Vol.159 (3), p.950-955

1998

Volltextzugriff (PDF)

Impact of the 17-Gene Genomic Prostate Score Assay on Low Risk Prostate Cancer Patients in the Veterans Health Care Administration

Value in health, 2016-05, Vol.19 (3), p.A167-A167

2016

Volltextzugriff (PDF)

1 – 25 von 332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase I/II Study of Preoperative Radiation and Docetaxel Activity Study for High-Risk Prostate Cancer

Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: Results from SWOG S0421

Erythrocyte fatty acids and prostate cancer risk: A comparison of methods

Phase I Study of Preoperative Radiation and Docetaxel for High-risk Prostate Cancer

Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer

Intermittent chemotherapy in metastatic androgen-independent prostate cancer

Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer

Statins and Prostate Cancer Risk: A Case-Control Study

Weekly High-Dose Calcitriol and Docetaxel in Metastatic Androgen-Independent Prostate Cancer

The Influence of the Pretreatment Host Immune State on Response to Radiation Therapy in High Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521 (Updated)

Delayed therapy with curative intent in a contemporary prostate cancer watchful‐waiting cohort

The Influence of the Pretreatment Host Immune Inflammatory State and Response to Radiation Therapy in High-Risk Adenocarcinoma of the Prostate: A Validation Study from NRG Oncology/RTOG 0521

SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION: A RARE COMPLICATION OF PROSTATE CANCER

Improved Detection of Prostate Cancer Using Classification and Regression Tree Analysis

Primary primitive neuroectodermal tumor of the kidney : Case report and review of the literature

Testosterone Loss and Estradiol Administration Modify Memory in Men

Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation

Multimodal therapy for neoplasms arising from a vesical diverticulum

Phase I/II study of preoperative intensity-modulated radiation therapy (IMRT) and docetaxel for high-risk prostate cancer: A platform for radiosensitizer development

A comparison of CT scan to transrectal ultrasound-measured prostate volume in untreated prostate cancer

Agent orange as a risk factor for high-grade prostate cancer detected on initial prostate biopsy

Agent orange as a risk factor for positive prostate biopsy

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

ANDROGEN DEPRIVATION WITH SALVAGE SURGERY FOR RADIORECURRENT PROSTATE CANCER: RESULTS AT 5-YEAR FOLLOWUP

Impact of the 17-Gene Genomic Prostate Score Assay on Low Risk Prostate Cancer Patients in the Veterans Health Care Administration

Suchergebnisse filtern